Opportunistic records can provide valuable information on certain species, including the critically endangered porbeagle shark (Lamna nasus). This note documents the occurrence of three juveniles, with approximate 120-, 88-, and 85-cm fork lengths respectively, observed along the coast of Asturias, Spain, in 2024. Given the three distinct scenarios in which these records respectively occurred (incidental capture, washed ashore and stranding), they emphasize the role of citizen science in identifying potential threats to this species, particularly in early stages of life, in a region that may be important and previously overlooked.
View Article and Find Full Text PDFRectal prolapse is a circumferential, full-thickness protrusion of the rectum through the anus, which, if not properly managed, may become incarcerated and pose a risk of strangulation. This pathology is rarely a medical emergency unless a complication is encountered. Such complications include infection, necrosis, perforation, incarceration, and uncontrolled pain.
View Article and Find Full Text PDFAnimals (Basel)
March 2024
The coronavirus SARS-CoV-2 has highlighted the criticality of an accurate and rapid diagnosis in order to contain the spread of the virus. Knowledge of the viral structure and its genome is essential for diagnosis development. The virus is still quickly evolving and the global scenario could easily change.
View Article and Find Full Text PDFThe development of new strategies to achieve a functional cure for HIV remains a priority. We tested a novel HIV therapeutic vaccine using unmodified mRNA (TMEP-B) and mRNA modified by 1-methyl-3'-pseudouridylyl (TMEP-Bmod) expressing both a multiepitopic sequences from Gag, Pol, and Nef proteins, including different CD4 and CD8 T-cell epitopes functionally associated with HIV control in transfected monocyte-derived dendritic cells (MDDCs) obtained from HIV infected patients. In vitro assays were used to test the mRNAs alone and in combination with immunomodulator agents, such as the TLR-7 agonist Vesatolimod and the PD-1 antagonist Nivolumab to try to improve HIV-specific cellular immune responses.
View Article and Find Full Text PDF